Paratesticular rhabdomyosarcoma: Report from the Italian and German Cooperative Group

A. Ferrari, G. Bisogno, M. Casanova, C. Meazza, L. Piva, G. Cecchetto, I. Zanetti, T. Pilz, A. Mattke, J. Treuner, M. Carli

Research output: Contribution to journalArticle

70 Citations (Scopus)

Abstract

Purpose: We report the experience of the German-Italian Cooperative Group with 216 pediatric patients with paratesticular rhabdomyosarcoma treated over 20 years. Patients and Methods: At diagnosis, 198 patients had localized disease and 18 had distant metastases. Among the nonmetastatic patients, complete tumor resection was performed in 83% of cases. Evaluation of the retroperitoneal lymph nodes changed over the years from routine surgical staging to radiologic assessment. All patients received chemotherapy, which was reduced in intensity and duration for patients with low-risk features in subsequent protocols. Radiotherapy was administered to 10% of patients. Results: Among 72 patients with a negative retroperitoneal computed tomography (CT) scan, surgical assessment detected nodal involvement in only one case. Among 23 patients with enlarged nodes on CT scans, surgery confirmed nodal spread in 65% of patients. No differences in the rate of nodal involvement were observed over the years. With a median follow-up of 110 months, 5-year survival was 85.5% forhe series as a whole, 94.6% for patients with localized disease, and 22.2% for metastatic cases. Retroperitoneal nodal recurrence was the major cause of treatment failure. Univariate analysis revealed the prognostic value of tumor invasiveness, size, and resectability, as well as of nodal involvement and age, in patients with localized tumor. Conclusion: The outcome for patients with localized paratesticular rhabdomyosarcoma is excellent, despite the reduction in chemotherapy over the years: an alkylating agent-free and anthracycline-free regimen is adequate treatment for low-risk patients. Surgical assessment of the retroperitoneum must be reserved for patients with enlarged nodes on CT scans. Children over 10 years old carry a higher risk of nodal involvement and relapse.

Original languageEnglish
Pages (from-to)449-455
Number of pages7
JournalJournal of Clinical Oncology
Volume20
Issue number2
DOIs
Publication statusPublished - Jan 15 2002

Fingerprint

Rhabdomyosarcoma
Tomography
Recurrence
Drug Therapy
Neoplasms
Alkylating Agents
Anthracyclines
Treatment Failure

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Paratesticular rhabdomyosarcoma : Report from the Italian and German Cooperative Group. / Ferrari, A.; Bisogno, G.; Casanova, M.; Meazza, C.; Piva, L.; Cecchetto, G.; Zanetti, I.; Pilz, T.; Mattke, A.; Treuner, J.; Carli, M.

In: Journal of Clinical Oncology, Vol. 20, No. 2, 15.01.2002, p. 449-455.

Research output: Contribution to journalArticle

Ferrari, A. ; Bisogno, G. ; Casanova, M. ; Meazza, C. ; Piva, L. ; Cecchetto, G. ; Zanetti, I. ; Pilz, T. ; Mattke, A. ; Treuner, J. ; Carli, M. / Paratesticular rhabdomyosarcoma : Report from the Italian and German Cooperative Group. In: Journal of Clinical Oncology. 2002 ; Vol. 20, No. 2. pp. 449-455.
@article{c5ef474ef14643d4815b28f2c1c73c45,
title = "Paratesticular rhabdomyosarcoma: Report from the Italian and German Cooperative Group",
abstract = "Purpose: We report the experience of the German-Italian Cooperative Group with 216 pediatric patients with paratesticular rhabdomyosarcoma treated over 20 years. Patients and Methods: At diagnosis, 198 patients had localized disease and 18 had distant metastases. Among the nonmetastatic patients, complete tumor resection was performed in 83{\%} of cases. Evaluation of the retroperitoneal lymph nodes changed over the years from routine surgical staging to radiologic assessment. All patients received chemotherapy, which was reduced in intensity and duration for patients with low-risk features in subsequent protocols. Radiotherapy was administered to 10{\%} of patients. Results: Among 72 patients with a negative retroperitoneal computed tomography (CT) scan, surgical assessment detected nodal involvement in only one case. Among 23 patients with enlarged nodes on CT scans, surgery confirmed nodal spread in 65{\%} of patients. No differences in the rate of nodal involvement were observed over the years. With a median follow-up of 110 months, 5-year survival was 85.5{\%} forhe series as a whole, 94.6{\%} for patients with localized disease, and 22.2{\%} for metastatic cases. Retroperitoneal nodal recurrence was the major cause of treatment failure. Univariate analysis revealed the prognostic value of tumor invasiveness, size, and resectability, as well as of nodal involvement and age, in patients with localized tumor. Conclusion: The outcome for patients with localized paratesticular rhabdomyosarcoma is excellent, despite the reduction in chemotherapy over the years: an alkylating agent-free and anthracycline-free regimen is adequate treatment for low-risk patients. Surgical assessment of the retroperitoneum must be reserved for patients with enlarged nodes on CT scans. Children over 10 years old carry a higher risk of nodal involvement and relapse.",
author = "A. Ferrari and G. Bisogno and M. Casanova and C. Meazza and L. Piva and G. Cecchetto and I. Zanetti and T. Pilz and A. Mattke and J. Treuner and M. Carli",
year = "2002",
month = "1",
day = "15",
doi = "10.1200/JCO.20.2.449",
language = "English",
volume = "20",
pages = "449--455",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "2",

}

TY - JOUR

T1 - Paratesticular rhabdomyosarcoma

T2 - Report from the Italian and German Cooperative Group

AU - Ferrari, A.

AU - Bisogno, G.

AU - Casanova, M.

AU - Meazza, C.

AU - Piva, L.

AU - Cecchetto, G.

AU - Zanetti, I.

AU - Pilz, T.

AU - Mattke, A.

AU - Treuner, J.

AU - Carli, M.

PY - 2002/1/15

Y1 - 2002/1/15

N2 - Purpose: We report the experience of the German-Italian Cooperative Group with 216 pediatric patients with paratesticular rhabdomyosarcoma treated over 20 years. Patients and Methods: At diagnosis, 198 patients had localized disease and 18 had distant metastases. Among the nonmetastatic patients, complete tumor resection was performed in 83% of cases. Evaluation of the retroperitoneal lymph nodes changed over the years from routine surgical staging to radiologic assessment. All patients received chemotherapy, which was reduced in intensity and duration for patients with low-risk features in subsequent protocols. Radiotherapy was administered to 10% of patients. Results: Among 72 patients with a negative retroperitoneal computed tomography (CT) scan, surgical assessment detected nodal involvement in only one case. Among 23 patients with enlarged nodes on CT scans, surgery confirmed nodal spread in 65% of patients. No differences in the rate of nodal involvement were observed over the years. With a median follow-up of 110 months, 5-year survival was 85.5% forhe series as a whole, 94.6% for patients with localized disease, and 22.2% for metastatic cases. Retroperitoneal nodal recurrence was the major cause of treatment failure. Univariate analysis revealed the prognostic value of tumor invasiveness, size, and resectability, as well as of nodal involvement and age, in patients with localized tumor. Conclusion: The outcome for patients with localized paratesticular rhabdomyosarcoma is excellent, despite the reduction in chemotherapy over the years: an alkylating agent-free and anthracycline-free regimen is adequate treatment for low-risk patients. Surgical assessment of the retroperitoneum must be reserved for patients with enlarged nodes on CT scans. Children over 10 years old carry a higher risk of nodal involvement and relapse.

AB - Purpose: We report the experience of the German-Italian Cooperative Group with 216 pediatric patients with paratesticular rhabdomyosarcoma treated over 20 years. Patients and Methods: At diagnosis, 198 patients had localized disease and 18 had distant metastases. Among the nonmetastatic patients, complete tumor resection was performed in 83% of cases. Evaluation of the retroperitoneal lymph nodes changed over the years from routine surgical staging to radiologic assessment. All patients received chemotherapy, which was reduced in intensity and duration for patients with low-risk features in subsequent protocols. Radiotherapy was administered to 10% of patients. Results: Among 72 patients with a negative retroperitoneal computed tomography (CT) scan, surgical assessment detected nodal involvement in only one case. Among 23 patients with enlarged nodes on CT scans, surgery confirmed nodal spread in 65% of patients. No differences in the rate of nodal involvement were observed over the years. With a median follow-up of 110 months, 5-year survival was 85.5% forhe series as a whole, 94.6% for patients with localized disease, and 22.2% for metastatic cases. Retroperitoneal nodal recurrence was the major cause of treatment failure. Univariate analysis revealed the prognostic value of tumor invasiveness, size, and resectability, as well as of nodal involvement and age, in patients with localized tumor. Conclusion: The outcome for patients with localized paratesticular rhabdomyosarcoma is excellent, despite the reduction in chemotherapy over the years: an alkylating agent-free and anthracycline-free regimen is adequate treatment for low-risk patients. Surgical assessment of the retroperitoneum must be reserved for patients with enlarged nodes on CT scans. Children over 10 years old carry a higher risk of nodal involvement and relapse.

UR - http://www.scopus.com/inward/record.url?scp=0037080455&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037080455&partnerID=8YFLogxK

U2 - 10.1200/JCO.20.2.449

DO - 10.1200/JCO.20.2.449

M3 - Article

C2 - 11786573

AN - SCOPUS:0037080455

VL - 20

SP - 449

EP - 455

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 2

ER -